By Chelsea Naso ( May 6, 2015, 8:24 AM EDT) -- Abbvie Inc., led by Wachtell Lipton Rosen & Katz, priced a $16.7 billion bond offering late Tuesday to help fund its $21 billion bid for cancer-drug maker Pharmacyclics Inc., making the U.S. pharmaceutical giant the latest to roll out a multibillion-dollar debt deal amid favorable interest rates....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.